STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1746 by analyst upside · 2026-06-27
USPH
U.S. Physical Therapy, Inc.
Healthcare · Market Cap $1B · P/E 132.3x
ANALYST PRICE TARGET
+36.2%
implied upside to consensus target
Current Price $68.78
Consensus Target $93.67
Bull Target $100.0
Bear Target $88.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
2
Hold
1
Sell
0
52-Week Low $58.19
52-Week High $93.5
YTD Return -11.6%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 132.3x
Forward P/E 20.2x
EPS (TTM) $0.52
PEG Ratio 2.41
Dividend Yield 2.65%
Revenue (TTM) $788M
Profit Margin 4.4%
52-WEEK RANGE
52-Week Low $58.19
52-Week High $93.5
Current Price $68.78
Bear Target $88.0
Bull Target $100.0
● Now $68.78 ● Target $93.67
TRADING DATA
Avg Volume 205K
YTD Return -11.6%
Analyst Count 6
Consensus Buy
Upside to Target +36.2%
Last Updated 2026-06-27

ANALYST SUMMARY

U.S. Physical Therapy, Inc. (USPH) is currently trading at $68.78 with a Wall Street consensus price target of $93.67, implying potential upside of 36.2% over the next 12 months. 6 analysts currently cover USPH, with a consensus rating of Buy - 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $100.0, while the most cautious has a target of $88.0.

USPH operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 11.6% year-to-date and is currently trading near the lower end of its 52-week range of $58.19 – $93.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for USPH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research — Reiterated
Outperform → Outperform 2026-05-13 Building track record
Citizens — Reiterated
Market Outperform → Market Outperform 2026-05-08 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-02-20 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-01-05 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2025-11-24 43% win rate (7 calls)
Barrington Research — Reiterated
Outperform → Outperform 2025-10-24 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2025-08-08 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2025-07-01 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
64
out of 100
Coverage depth
15/30
Consensus clarity
27/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →